Related Experiment Video
Updated: Aug 18, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3
Noriko Yoneda-Kato1, Kiichiro Tomoda, Mari Umehara
1Department of Animal Molecular Genetics, Graduate School of Biological Sciences, Nara Institute of Science and Technology, Takayama, Ikoma, Nara, Japan. noriko-k@bs.naist.jp
Abstract:
Myeloid leukemia factor 1 (MLF1) was first identified as the leukemic fusion protein NPM-MLF1 generated by the t(3;5)(q25.1;q34) chromosomal translocation. Although MLF1 expresses normally in a variety of tissues including hematopoietic stem cells and the overexpression of MLF1 correlates with malignant transformation in human cancer, little is known about how MLF1 is involved in the regulation of cell growth. Here we show that MLF1 is a negative regulator of cell cycle progression functioning upstream of the tumor suppressor p53. MLF1 induces p53-dependent cell cycle arrest in murine embryonic fibroblasts. This action requires a novel binding partner, subunit 3 of the COP9 signalosome (CSN3). A reduction in the level of CSN3 protein with small interfering RNA abrogated MLF1-induced G1 arrest and impaired the activation of p53 by genotoxic stress. Furthermore, ectopic MLF1 expression and CSN3 knockdown inversely affect the endogenous level of COP1, a ubiquitin ligase for p53. Exogenous expression of COP1 overcomes MLF1-induced growth arrest. These results indicate that MLF1 is a critical regulator of p53 and suggest its involvement in leukemogenesis through a novel CSN3-COP1 pathway.
Insights
Myeloid leukemia factor 1 (MLF1) negatively regulates cell growth by inducing p53-dependent cell cycle arrest. This process involves the COP9 signalosome subunit 3 (CSN3) and impacts p53 ubiquitination via COP1, suggesting a role in leukemogenesis.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Myeloid leukemia factor 1 (MLF1) is linked to cancer, but its role in cell growth regulation is unclear.
- MLF1 overexpression correlates with malignant transformation in human cancers.
- MLF1 is normally expressed in hematopoietic stem cells and other tissues.
Purpose of the Study:
- To elucidate the mechanism by which MLF1 regulates cell growth.
- To investigate the interaction of MLF1 with cell cycle regulators.
- To identify novel binding partners and pathways involved in MLF1 function.
Main Methods:
- Cell cycle analysis in murine embryonic fibroblasts.
- Small interfering RNA (siRNA) knockdown of CSN3.
- Western blotting to assess protein levels (p53, CSN3, COP1).
- Analysis of p53 activation and ubiquitination.
Main Results:
- MLF1 acts as a negative regulator of cell cycle progression, functioning upstream of p53.
- MLF1 induces p53-dependent G1 cell cycle arrest.
- CSN3 is a novel binding partner required for MLF1's function.
- CSN3 knockdown abrogates MLF1-induced arrest and impairs p53 activation.
- MLF1 and CSN3 levels inversely correlate with COP1, a p53 ubiquitin ligase.
- COP1 overexpression rescues MLF1-induced growth arrest.
Conclusions:
- MLF1 is a critical regulator of p53.
- MLF1 influences p53 stability and activation through a novel CSN3-COP1 pathway.
- This pathway suggests a role for MLF1 in leukemogenesis.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Master Transcription Regulators
Differentiation of Common Myeloid Progenitor Cells
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

